ANIXA BIOSCIENCES, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ANIXA BIOSCIENCES, INC. (ANIX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $64.00 thousand as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-09-09
- 2026-07-31: Lessee, Operating Lease, Liability, to be Paid, Year One $64.00K.
- 2026-04-30: Lessee, Operating Lease, Liability, to be Paid, Year One $64.00K.
- 2026-01-31: Lessee, Operating Lease, Liability, to be Paid, Year One $64.00K.
- 2025-10-31: Lessee, Operating Lease, Liability, to be Paid, Year One $63.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-07-31 | $64.00K 10-Q · filed 2026-09-09 |
| 2026-04-30 | $64.00K 10-Q · filed 2026-06-10 |
| 2026-01-31 | $64.00K 10-Q · filed 2026-03-09 |
| 2025-10-31 | $63.00K 10-K · filed 2026-01-12 |
| 2025-07-31 | $63.00K 10-Q · filed 2025-09-10 |
| 2025-04-30 | $63.00K 10-Q · filed 2025-05-28 |
| 2025-01-31 | $63.00K 10-Q · filed 2025-03-11 |
| 2024-10-31 | $56.00K 10-K · filed 2025-01-10 |
| 2024-07-31 | $56.00K 10-Q · filed 2024-09-06 |
| 2024-04-30 | $70.00K 10-Q · filed 2024-06-04 |
| 2024-01-31 | $70.00K 10-Q · filed 2024-03-12 |
| 2023-10-31 | $67.00K 10-K · filed 2024-01-16 |
| 2023-07-31 | $67.00K 10-Q · filed 2023-09-06 |
| 2023-04-30 | $67.00K 10-Q · filed 2023-06-14 |
| 2023-01-31 | $67.00K 10-Q · filed 2023-03-17 |
| 2022-10-31 | $66.00K 10-K · filed 2023-01-04 |
| 2022-07-31 | $66.00K 10-Q · filed 2022-09-09 |
| 2022-04-30 | $32.00K 10-Q · filed 2022-06-10 |
| 2022-01-31 | $48.00 10-Q · filed 2022-03-11 |
| 2021-10-31 | $63.58K 10-K · filed 2022-01-04 |
| 2020-07-31 | $59.14K 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |